Effects of an infrared pulsed laser device (IPLD) over apoptosis in cancer cells

Bioelectromagnetics

Volumn 26, Issue 6, 2005, Pages 523-524

  Santana Blank, Luis ^a  

^a Foundation for Interdisciplinary Research and Development   (Venezuela)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER CELLS;

CANCER CELLS; INFRARED PULSED LASER DEVICES;

CELL DEATH;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; CANCER CELL; CELL MEMBRANE PERMEABILITY; CONTROLLED STUDY; ELECTROMAGNETIC FIELD; HUMAN; HUMAN CELL; INFRARED RADIATION; LASER; LETTER; LYMPHOCYTE; PRIORITY JOURNAL; THERMODYNAMICS;

EID: 24344432798     PISSN: 01978462     EISSN: None     Source Type: Journal    
DOI: 10.1002/bem.20130     Document Type: Letter

References (13)

1. Kujawa J, Zavodnik IB, Lapshina A, Labieniec M, Bryszewska M. 2004. Cell survival, DNA, and protein damage in B14 cells under low-intensity near-infrared (810 nm) laser irradiation. Photomed Laser Surg 22:504-508.
2. Radeva M, Berg H. 2004. Differences in lethality between cancer cells and human lymphocytes caused by LF-electromagnetic fields. Bioelectromagnetics 25:503-507.
3. Rodriguez-Santana E, Santana-Blank LA, Reyes H, Santana-Rodriguez KE, Hunger M, Orellana R, Onega D. 2003. HNMR spin-lattice and correlation times of burned soft-tissue after treatment with an infrared pulsed laser device. Lasers Surg Med 33:190-198.
4. Santana-Blank LA. 1993. United States Patent- No. 5,231,984 and other existing patents.
5. Santana-Blank L. 2003. Modulated low-energy near-infrared (NIR) lasers and cancer: An invitation to discuss a new treatment approach. Lasers Surg Med 32:1-2.
6. Santana-Blank L. 2004a. Contraindications in noninvasive laser therapy, truth and fiction. Photomed Laser Surg 22:442.
7. Santana-Blank L. 2004b. Exchanging ideas about research that is both methodologically sound and scientifically relevant. Photomed Laser Surg 22:442-443.
8. Santana-Blank LA, Castes M, Rojas ME, Vargas F, Scott-Algara D. 1992. Evaluation of serum levels of tumor necrosis factor-(TNF-a) and soluble IL-2 receptor (sIL-2R) and CD4. CD8 and natural killer (NK) populations during infrared pulsed laser device (IPLD) treatment. Clin Exp Immunol 90:43-48.
9. Santana-Blank LA, Rodriguez-Santana E, Scott-Algara D, Hunger M, Santana-Rodriguez KE, Orellana R. 2000. Short-term bioeffects of an infrared pulsed laser device on burned rat skin monitored by transverse relaxation times (NMR). Lasers Surg Med 27:411-419.
10. Santana-Blank LA, Rodríguez-Santana E, Vargas F, Santana-Rodríguez KE. 2002a. Photo-induced Cytomorphologic changes in an advanced cancer clinical trial. Lasers Surg Med 30:19-26.
11. Santana-Blank LA, Rodriguez-Santana E, Vargas F, Reyes H, Fernandez-Andrade P, Rukos S, Santana-Rodriguez KE. 2002b. Phase I trial of an infrared pulsed laser device in patients with advanced neoplasias. Clin Cancer Res 8:3082-3091.
12. Santana-Blank LA, Reyes H, Rodriguez-Santana E, Santana-Rodriguez KE. 2004c. Microdensitometry of T2-weighted magnetic resonance (MR) images from patients with advanced neoplasias in a phase I clinical trial of an infrared pulsed laser device (IPLD). Lasers Surg Med 34:398-406.
13. Traitcheva N, Angelova P, Radeva M, Berg H. 2003. ELF fields and photooxidation yielding lethal effects on cancer cells. Bioelectromagnetics 24:148-150.